eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
4/2024
vol. 20
 
Share:
Share:
Original paper

Relationship between uric acid to HDL ratio and extent and severity of coronary artery disease

Mehmet Yaman
1
,
Ali Y. Kilinc
2
,
Fatih Öztürk
1
,
Mehmet Coşkun
3
,
Ramazan Duz
4
,
Yilmaz Gunes
3

  1. Cardiology Department, Echomar Hospital, Zonguldak, Turkey
  2. Department of Cardiology, Haseki Training and Research Hospital, Istanbul, Turkey
  3. Cardiology Department, Bolu Abant Izzet Baysal University, Bolu, Turkey
  4. Cardiology Department, Van Yuzuncuyıl University, Van, Turkey
Adv Interv Cardiol 2024; 20, 4 (78): 401–405
Online publish date: 2024/11/14
Article file
Get citation
 
 

Summary

Coronary artery disease (CAD) is a chronic and inflammatory disease. SYNTAX and Gensini scoring systems are used to evaluate CAD extent and severity. We aimed to investigate the relationship between uric acid-high-density lipoprotein ratio (UHR) and the extent and severity of CAD and its correlation with SYNTAX and Gensini scoring systems. As a result of the study, the UHR value was found to be significantly higher in patients with critical coronary stenosis and was found to be correlated with SYNTAX and Gensini scores. UHR can be used before invasive evaluation to predict the presence, severity, and extent of CAD.

Introduction

Coronary artery disease (CAD) is common worldwide and is a significant cause of morbidity and mortality [1, 2]. CAD is a chronic and inflammatory disease that is mainly caused by atherosclerosis [3]. SYNTAX (The SYNergy between percutaneous coronary intervention with TAXus and cardiac surgery) and Gensini scoring systems have been developed for determining the extent and severity of CAD. Validation of both scoring systems has been demonstrated in previous studies [46].

High-density lipoprotein (HDL) carries excess cholesterol from peripheral tissues to the liver and is distinguished from other lipoproteins by this feature [7]. HDL has anti-inflammatory and antioxidant properties. Although it is known that low HDL levels increase cardiovascular risk, the positive effects of high HDL levels on the risk of myocardial infarction have not been demonstrated [8]. For this reason, the use of HDL alone as a cardiovascular risk factor becomes doubtful, and strengthening this value with additional parameters is on the agenda.

Uric acid (UA) is the end product of purine metabolism [9]. Previous studies have shown that UA level is associated with cardiovascular diseases [10, 11]. Additionally, studies have shown that UA level predicts the distribution and severity of CAD [12]. It is thought that endothelial dysfunction, activation of the renin angiotensin aldosterone system and increased oxidative stress as a result of increased xanthine oxidase activity may cause this situation [13]. With these effects, hyperuricemia promotes the development of atherosclerosis and plaque.

Based on this information, it is known that UA to HDL ratio (UHR) increases in inflammatory conditions, and previous studies have shown that it increases in metabolic syndrome, thyroiditis and diabetes [14, 15]. In addition, a relationship between UHR level and incidental CAD has been shown [16].

Aim

We aimed to investigate the relationship between UHR and the extent and severity of CAD and its correlation with the SYNTAX and Gensini scoring systems.

Material and methods

Study subjects

This study is a retrospective observational cohort study. From May 2022 to October 2023, a total of 894 patients, over 18 years old, who underwent coronary angiography for highly suspected CAD were included in the study. 612 participants with ≥ 70% stenosis in at least one epicardial coronary artery were designated as the patient group, and 282 participants without critical coronary stenosis were designated as the control group. Exclusion criteria were: other cardiac diseases (heart valve diseases, myocardial diseases), drug uses for hyperlipidemia and hyperuricemia, chronic kidney disease, decompensated heart failure and left ventricular ejection fraction (LVEF) < 50%.

Data collection

All patients were evaluated for the presence of cardiovascular risk factors such as hypertension, hyperlipidemia, diabetes mellitus, age, sex, diabetes mellitus (DM), body surface area (BSA), and smoking status. Hypertension was defined as systolic blood pressure ≥ 140 mm Hg and/or diastolic blood pressure ≥ 90 mm Hg, previously diagnosed hypertension, or use of any antihypertensive medications. Diabetes mellitus was defined as fasting plasma glucose (FPG) levels more than 126 mg/dl in multiple measurements, previously diagnosed diabetes mellitus, or use of antidiabetic medications such as oral antidiabetic agents or insulin.

Blood samples were obtained in the morning after overnight fasting (8 h minimum) to determine blood biochemical parameters, including white blood cells (WBC), FPG, triglyceride (TG), serum total cholesterol (TC), low-density lipoprotein (LDL), HDL, estimated glomerular filtration rate (eGFR), and UA. UHR was defined as the ratio of UA (mg/dl) to HDL (mg/dl). LVEF was determined during hospitalization using 2D echocardiography.

The SYNTAX score was calculated via the sum of points assigned to lesions with ≥ 50% stenosis in separate vessels having ≥ 1.5 mm diameter [5]. Thereafter patients having a score ≤ 22 were defined as the low risk group, those having a score of 23–32 as the intermediate risk group and those having a score ≥ 33 as the high risk group according to current US/European guidelines [17].

For Gensini score calculation, lesions with ≤ 25% stenosis were given 1 point, 26–50% stenosis 2 points, 51–75% stenosis 4 points, 76–90% stenosis 8 points, 91–99% stenosis 16 points and total occlusion 32 points. Thereafter these points were multiplied by 5 for left main coronary artery lesions, by 2.5 for proximal left anterior descending (LAD) or circumflex artery coronary artery lesions, by 1.5 for mid LAD artery lesions, by 1 for right coronary artery, distal LAD artery, posterolateral artery, and obtuse marginal artery lesions and by 0.5 for other lesions [18, 19].

Statistical analysis

The data of the present study were analyzed using IBM SPSS Statistics v. 27.0 for Mac. Categorical variables were presented as frequency and percentage and continuous variables were presented as mean ± standard deviation (SD). Categorical variables were compared with the χ2 test. After evaluation with the Kolmogorov-Smirnov test normally distributed continuous variables were compared via Student’s t test and others with the Mann-Whitney U test. Pearson correlation analysis was used for assessment of correlation. A p-value of <0.05 was considered as statistically significant.

All data were analyzed using IBM SPSS Statistics v. 27.0 for Mac. Categorical variables were expressed as frequency and percentage; continuous variables were expressed as mean ± SD. The normal distribution of the data was evaluated using the Kolmogorov-Smirnov test. The variables with normal distribution were compared using Student’s t test and the Mann-Whitney U test was used when the normal distribution was not provided.

Results

A total of 894 participants were included in the study. 495 (55.4%) of the participants were male. The rates of diabetes, hypertension and smoking, which are cardiovascular risk factors, were similar in both groups. Considering the laboratory parameters, they were found to be similar in both groups, except for uric acid level and UHR. Baseline characteristics are shown in Table I. 347 patients included in the study had diabetes and 471 patients had hypertension. UHR level was higher in patients with diabetes than in those without (0.3541 ±0.10, 0.1803 ±0.10 respectively, p < 0.01). Similarly, UHR level was found to be higher in patients with hypertension than in those without (0.3083 ±0.1397, 0.1803 ±0.10 respectively, p < 0.01). Regression analysis including age, HT, DM, smoking, LDL-C level and UHR had R2 for prediction of significant CAD and among the parameters only DM and UHR were independent significant predictors.

Table I

Baseline characteristics

ParameterPatient group (n = 612)Control group (n = 282)P-value
Age, mean ± SD [years]62.53 ±14.7462.31 ±14.830.92
Diabetes, n (%)216 (35.3)115 (40.8)0.20
Hypertension, n (%)132 (21.6)52(18.4)0.41
Smoking, n (%)303 (49.5)157 (55.7)0.31
LDL, mean ± SD [mg/dl]109.74 ±37.54106.02 ±390.17
Total cholesterol, mean ± SD [mg/dl]159.77 ±40.37160.54 ±39.240.79
Triglyceride, mean ± SD [mg/dl]281.75 ±62282.29 ±620.90
HDL, mean ± SD [mg/dl]40.84 ±10.9741.41 ±10.320.46
Uric acid, mean ± SD [mg/dl]7.58 ±2.555.71 ±1.46< 0.01
Glucose, mean ± SD [mg/dl]123.09 ±54.14126.46 ±56.430.39
UHR, mean ± SD0.2016 ±0.0940.1461 ±0.05< 0.01
GFR, mean ± SD [ml/min]84.69 ±38.3585.76 ±39.810.70
BSA, mean ± SD [m2]1.65 ±0.0911.65 ±0.0860.74

[i] BSA – body surface area, GFR – glomerular filtration rate, HDL – high-density lipoprotein, LDL – low-density lipoprotein, UHR – uric acid/HDL ratio.

The mean SYNTAX score of the patient group was 23.30 ±10.86 and the mean Gensini score was 91.74 ±63.43. In the correlation analysis, it was found that UHR had positive correlations with both SYNTAX and Gensini score (p < 0.01). Patients were classified according to their SYNTAX score and their relationship with UHR was analyzed. The patients’ SYNTAX score increased in parallel to the increase in UHR (Figure 1).

Figure 1

UHR increase with SYNTAX score increase. On the horizontal axis, 1: SYNTAX score < 22, 2: Syntax score 22–32, 3: SYNTAX > 32

/f/fulltexts/PWKI/55149/PWKI-20-55149-g001_min.jpg

In the ROC curve analysis of UHR and CAD, the cut-off UHR value of 0.16 had a sensitivity of 61.1% and specificity of 38.7% for CAD prediction (AUC = 0.669 (0.634–0.704)) (Figure 2).

Figure 2

ROC curve analysis

/f/fulltexts/PWKI/55149/PWKI-20-55149-g002_min.jpg

Discussion

Our study demonstrated that UHR is higher in patients with critical epicardial coronary stenosis. However, UHR showed a positive correlation with SYNTAX and Gensini scores. This result demonstrates the positive association between CAD severity and extent and high UHR levels.

UHR has been shown to be predictive of metabolic syndrome in diabetic and non-diabetic individuals [20, 21]. Studies investigating the relationship between UHR and cardiovascular risk factors such as hypertension and diabetes have shown that high UHR levels were associated with HT and DM [2224]. In our study, similar to the literature, UHR level was found to be significantly higher in diabetic patients than in non-diabetic patients and in patients with hypertension compared to those without. Xinhe Zhou et al. reported that elevated UHR was significantly correlated with insulin resistance and could be used as an indicator of insulin resistance in patients with type 2 diabetes mellitus [25].

Park et al. investigated the predictive value of UHR for CAD in non-diabetic patients. They found that high UHR values were positively associated with incident CAD in patients without diabetes. They also stated that UHR could be used as a cardiovascular risk marker in the preclinical stage [16]. In the study conducted by Li et al., patients with moderate (40–70%) coronary stenosis and who underwent fractional flow reserve (FFR) measurement for hemodynamic evaluation were included. According to the FFR result, the patients were divided into two groups – hemodynamically significant and non-significant – and their UHR levels were compared with each other. It was observed that the UHR level was significantly higher in patients with hemodynamically significant coronary stenosis [26]. In a study, the effect of UA and HDL levels on prognosis in patients with acute myocardial infarction was evaluated. The coexistence of high UA and low HDL-C was found to have a synergistic effect and provide further information for risk stratification of AMI patients [27]. In our study, we found higher UHR levels in patients with critical coronary stenosis, which was similar to studies in the literature. Additionally, we observed that UHR levels were correlated with SYNTAX and Gensini scores, which predict the prevalence and severity of CAD. Another striking aspect of our study was that the presence of diabetes, hypertension, smoking, serum total cholesterol and LDL levels, which are classical cardiovascular risk factors, was found to be similar in both the patient group and the control group, and only DM and UHR had significant predictive value for presence of CAD. This result showed that UHR is a good predictor that can be used in addition to classical risk factors in predicting the extent and severity of CAD disease. Therefore we can speculate that patients with CAD risk factors and suspicious symptoms having higher UHR levels (> 0.16 in our study) may be evaluated for presence of significant CAD more seriously.

Conclusions

This study showed that UHR is higher in patients with critical epicardial coronary stenosis. UHR is an easy-to-use parameter that can be used before invasive evaluation to predict the presence, severity, and extent of CAD. Stronger evidence-based results can be achieved with larger multi-center prospective studies on this subject.

Ethical approval

The study was approved by the ethics committee (Bolu Abant Izzet Baysal University, Bolu, Turkey, No: 2023/391). All procedures performed in studies involving human participants were conducted in accordance with the ethical standards of the institutional and/or national research committee, the 1975 Declaration of Helsinki, and subsequent amendments or comparable ethical standards.

Conflict of interest

The authors declare no conflict of interest.

References

1 

Lopez AD, Mathers CD, Ezzati M, et al. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006; 367: 1747-57.

2 

Onat A, Yazici M, Sari I, et al. The risk factor survey of 2003 in western Turkey indicates trend to declining coronary mortality and urban overall mortality. Arch Turk Soc Cardiol 2003; 31: 762-9.

3 

Lusis AJ. Atherosclerosis. Nature 2000; 6801: 233-41.

4 

Davies MJ. The pathophysiology of acute coronary syndromes. Heart 2000; 83: 361-6.

5 

Sianos G, Morel MA, Kappetein AP, et al. The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005; 1: 219-27.

6 

Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol 1983; 51: 606-98.

7 

Navab M, Reddy ST, Van Lenten BJ, et al. HDL and cardiovascular disease: atherogenic and atheroprotective mechanisms. Nat Rev Cardiol 2011; 8: 222-32.

8 

Voight BF, Peloso GM, Orho-Melander M, et al. Plasma HDL cholesterol and risk of myocardial infarction: a Mendelian randomisation study. Lancet 2012; 380: 572-80.

9 

Maiuolo J, Oppedisano F, Gratteri S, et al. Regulation of uric acid metabolism and excretion. Int J Cardiol 2016; 213: 8-14.

10 

Fenech G, Rajzbaum G, Mazighi M, et al. Serum uric acid and cardiovascular risk: state of the art and perspectives. Joint Bone Spine 2014; 81: 392-7.

11 

Ndrepepa G. Uric acid and cardiovascular disease. Clin Chim Acta 2018; 484: 150-63.

12 

Xiong Z, Zhu C, Qian X, et al. Predictors of clinical SYNTAX score in coronary artery disease: serum uric acid, smoking, and Framingham risk stratification. J Invasive Cardiol 2011; 23: 501-4.

13 

Kimura Y, Tsukui D, Kono H. Uric acid in inflammation and the pathogenesis of atherosclerosis. Int J Mol Sci 2021; 22: 12394.

14 

Kurtkulagi O, Tel BMA, Kahveci G, et al. Hashimoto’s thyroiditis is associated with elevated serum uric acid to high density lipoprotein-cholesterol ratio. Rom J Intern Med 2021; 59: 403-8.

15 

Aktas G, Kocak MZ, Bilgin S, et al. Uric acid to HDL cholesterol ratio is a strong predictor of diabetic control in men with type 2 diabetes mellitus. Aging Male 2020; 23: 1098-102.

16 

Park B, Jung DH, Lee YJ. Predictive value of serum uric acid to HDL cholesterol ratio for incident ischemic heart disease in non-diabetic Koreans. Biomedicines 2022; 10: 1422.

17 

Knuuti J, Wijns W, Saraste A, et al. ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes. Eur Heart J 2020; 41: 407-77.

18 

Rampidis GP, Benetos G, Benz DC, et al. A guide for Gensini Score calculation. Atherosclerosis 2019; 287: 181-3.

19 

Sinning C, Lillpopp L, Appelbaum S, et al. Angiographic score assessment improves cardiovascular risk prediction: the clinical value of SYNTAX and Gensini application. Clin Res Cardiol 2013; 102: 495-503.

20 

Kocak MZ, Aktas G, Erkus E, et al. Serum uric acid to HDL-cholesterol ratio is a strong predictor of metabolic syndrome in type 2 diabetes mellitus. Rev Assoc Med Bras 2019; 65: 9-15.

21 

Yazdi F, Baghaei MH, Baniasad A, et al. Investigating the relationship between serum uric acid to high-density lipoprotein ratio and metabolic syndrome. Endocrinol Diabetes Metab 2022; 5: e00311.

22 

Uzeli U, Doğan AG. The relationship between diabetic neuropathy and uric acid/high-density lipoprotein ratio in patients with type-2 diabetes mellitus. Cureus 2023; 5: e45151.

23 

Di Bonito P, Rosanio FM, Marcovecchio ML, et al. Uric acid and cardiometabolic risk by gender in youth with type 1 diabetes. Sci Rep 2022; 12: 12153.

24 

Lee SW, Kim HC, Nam C, et al. Age-differential association between serum uric acid and incident hypertension. Hypertens Res 2019; 42: 428-37.

25 

Zhou X, Xu J. Association between serum uric acid-to-high-density lipoprotein cholesterol ratio and insulin resistance in patients with type 2 diabetes mellitus. J Diabetes Investig 2024; 15: 113-20.

26 

Li F, Zhao D, Li Q, et al. Uric acid to high-density lipoprotein cholesterol ratio is a novel marker to predict functionally significant coronary artery stenosis. J Interv Cardiol 2022; 2022: 9057832.

27 

Yang Y, Zhang J, Jia L, et al. The interaction between uric acid and high-density lipoprotein cholesterol on the prognosis of patients with acute myocardial infarction. Front Cardiovasc Med 2023; 10: 1226108.

Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
 
Quick links
© 2025 Termedia Sp. z o.o.
Developed by Bentus.